Stock Information

Keros Therapeutics Inc (KROS)

Keros Therapeutics Inc logo
Ticker Symbol: KROS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $576.33 mil
Piotroski score: 7
PE Ratio: 6.5755
EPS (TTM): 1.5435
Revenue (TTM): $6.07 M
Dividend Yield: N/A%
ROE: 9.51%

Latest News

Key Financials

Financial data not available